RT can promote the upregulation of immune checkpoints like PD-L1 on tumor cells, which, while providing a potential mechanism of immune escape, also presents a target for blockade by PD-1/PD-L1 inhibitors [19]. The gene discussed is CD274; the disease is neoplasm.